T1	tradename 104 110	CIMZIA
T2	tradename 173 188	CIMZIA. CIMZIA
T3	nanoparticle 190 209	certolizumab pegol)
T4	routeofadministration 229 241	subcutaneous
T5	tradename 246 252	CIMZIA
T6	nanoparticle 254 273	certolizumab pegol)
T7	routeofadministration 289 301	subcutaneous
T8	fdaapprovaldate 329 333	2008
T9	adversereaction 344 362	SERIOUS INFECTIONS
T10	adversereaction 367 377	MALIGNANCY
T11	adversereaction 468 486	serious infections
T12	adversereaction 517 522	death
T13	adversereaction 533 596	tuberculosis (TB), bacterial sepsis, invasive fungal infections
T14	adversereaction 606 621	histoplasmosis)
T15	tradename 693 699	CIMZIA
T16	adversereaction 747 764	serious infection
T17	adversereaction 768 774	sepsis
T18	tradename 875 881	CIMZIA
T19	adversereaction 1013 1021	Lymphoma
T20	adversereaction 1032 1045	malignancies,
T21	tradename 1149 1155	CIMZIA
T22	tradename 1175 1181	CIMZIA
T23	tradename 1601 1601	
T24	indication 1699 1714	Crohn's disease
T25	indication 1943 1963	rheumatoid arthritis
T26	indication 2021 2041	psoriatic arthritis.
T27	indication 2090 2112	ankylosing spondylitis
T28	tradename 2196 2196	
T29	routeofadministration 2216 2228	subcutaneous
T30	tradename 2261 2267	CIMZIA
T31	dose 2271 2277	400 mg
T32	routeofadministration 2292 2304	subcutaneous
T33	indication 2331 2346	Crohn's Disease
T34	dose 2363 2369	400 mg
T35	dose 2436 2442	400 mg
T36	frequency 2443 2459	every four weeks
T37	indication 2460 2480	Rheumatoid Arthritis
T38	dose 2497 2503	400 mg
T39	dose 2548 2554	200 mg
T40	frequency 2555 2573	every other week;
T41	dose 2598 2604	400 mg
T42	frequency 2605 2618	every 4 weeks
T43	indication 2637 2656	Psoriatic Arthritis
T44	dose 2673 2679	400 mg
T45	dose 2723 2729	200 mg
T46	dose 2773 2779	400 mg
T47	frequency 2780 2793	every 4 weeks
T48	indication 2813 2835	Ankylosing Spondylitis
T49	dose 2853 2859	400 mg
T50	routeofadministration 2872 2884	subcutaneous
T51	dose 2956 2962	200 mg
T52	frequency 2963 2979	every other week
T53	dose 2983 2989	400 mg
T54	frequency 2990 3004	every 4 weeks.
T55	adversereaction 3468 3486	Serious infections
T56	tradename 3502 3508	CIMZIA
T57	tradename 3593 3599	CIMZIA
T58	adversereaction 3646 3672	Invasive fungal infections
T59	tradename 3722 3729	CIMZIA,
T60	adversereaction 3860 3868	lymphoma
T61	adversereaction 3879 3891	malignancies
T62	adversereaction 3966 3980	Heart failure,
T63	adversereaction 4030 4041	Anaphylaxis
T64	adversereaction 4045 4071	serious allergic reactions
T65	adversereaction 4098 4128	Hepatitis B virus reactivation
T66	tradename 4171 4178	CIMZIA.
T67	tradename 4271 4277	CIMZIA
T68	adversereaction 4324 4346	Demyelinating disease,
T69	adversereaction 4400 4424	Cytopenias, pancytopenia
T70	tradename 4523 4529	CIMZIA
T71	adversereaction 4546 4565	Lupus-like syndrome
T72	tradename 4573 4579	CIMZIA
T73	adversereaction 4766 4806	upper respiratory tract infection, rash,
T74	adversereaction 4811 4834	urinary tract infection
T75	company 4889 4898	UCB, Inc.
T76	adversereaction 5101 5119	serious infections
T77	tradename 5173 5179	CIMZIA
T78	indication 5730 5745	Crohn's Disease
T79	indication 5751 5771	Rheumatoid Arthritis
T80	indication 5777 5796	Psoriatic Arthritis
T81	indication 5802 5824	Ankylosing Spondylitis
T82	indication 5859 5874	Crohn's Disease
T83	indication 5880 5900	Rheumatoid Arthritis
T84	indication 5906 5925	Psoriatic Arthritis
T85	indication 5931 5953	Ankylosing Spondylitis
T86	tradename 5993 5999	CIMZIA
T87	tradename 6083 6089	CIMZIA
T88	adversereaction 6272 6290	Serious Infections
T89	adversereaction 6296 6308	Malignancies
T90	adversereaction 6314 6327	Heart Failure
T91	adversereaction 6333 6359	Hypersensitivity Reactions
T92	adversereaction 6365 6395	Hepatitis B Virus Reactivation
T93	indication 7154 7169	Crohn's Disease
T94	indication 7176 7196	Rheumatoid Arthritis
T95	indication 7203 7222	Psoriatic Arthritis
T96	indication 7229 7251	Ankylosing Spondylitis
T97	adversereaction 7727 7745	SERIOUS INFECTIONS
T98	adversereaction 7750 7760	MALIGNANCY
T99	tradename 7803 7809	CIMZIA
T100	adversereaction 7847 7865	serious infections
T101	adversereaction 7902 7907	death
T102	co-administereddrug 8070 8082	methotrexate
T103	co-administereddrug 8086 8102	corticosteroids.
T104	tradename 8104 8110	CIMZIA
T105	adversereaction 8158 8175	serious infection
T106	adversereaction 8179 8186	sepsis.
T107	adversereaction 8234 8247	tuberculosis,
T108	tradename 8452 8458	CIMZIA
T109	tradename 8544 8550	CIMZIA
T110	adversereaction 8567 8594	Invasive fungal infections,
T111	adversereaction 8605 8683	histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis,
T112	adversereaction 8688 8703	pneumocystosis.
T113	tradename 9231 9237	CIMZIA
T114	tradename 9471 9478	CIMZIA,
T115	adversereaction 9692 9711	MALIGNANCY Lymphoma
T116	adversereaction 9722 9735	malignancies,
T117	tradename 9839 9845	CIMZIA
T118	tradename 9896 9902	CIMZIA
T119	indication 9981 9996	Crohn's Disease
T120	tradename 9997 10003	CIMZIA
T121	indication 10052 10067	Crohn's disease
T122	indication 10230 10250	Rheumatoid Arthritis
T123	tradename 10251 10257	CIMZIA
T124	indication 10334 10361	rheumatoid arthritis (RA).
T125	indication 10543 10562	Psoriatic Arthritis
T126	tradename 10563 10569	CIMZIA
T127	indication 10631 10657	psoriatic arthritis (PsA).
T128	indication 10664 10686	Ankylosing Spondylitis
T129	tradename 10687 10693	CIMZIA
T130	indication 10747 10775	ankylosing spondylitis (AS).
T131	tradename 10836 10842	CIMZIA
T132	routeofadministration 10862 10874	subcutaneous
T133	dose 11023 11029	400 mg
T134	routeofadministration 11059 11071	subcutaneous
T135	dose 11086 11093	200 mg)
T136	tradename 11454 11460	CIMZIA
T137	indication 11588 11603	Crohn's Disease
T138	tradename 11642 11648	CIMZIA
T139	dose 11652 11658	400 mg
T140	routeofadministration 11673 11685	subcutaneous
T141	dose 11701 11708	200 mg)
T142	dose 11826 11832	400 mg
T143	frequency 11833 11850	every four weeks.
T144	indication 11857 11877	Rheumatoid Arthritis
T145	tradename 11902 11908	CIMZIA
T146	indication 11933 11953	rheumatoid arthritis
T147	dose 11957 11963	400 mg
T148	routeofadministration 11979 11991	subcutaneous
T149	dose 12006 12013	200 mg)
T150	dose 12058 12064	200 mg
T151	frequency 12065 12082	every other week.
T152	tradename 12108 12114	CIMZIA
T153	dose 12115 12121	400 mg
T154	frequency 12122 12135	every 4 weeks
T155	indication 12191 12210	Psoriatic Arthritis
T156	tradename 12235 12241	CIMZIA
T157	indication 12266 12285	psoriatic arthritis
T158	dose 12289 12295	400 mg
T159	routeofadministration 12309 12321	subcutaneous
T160	dose 12336 12342	200 mg
T161	dose 12392 12398	200 mg
T162	frequency 12399 12416	every other week.
T163	tradename 12442 12448	CIMZIA
T164	dose 12449 12455	400 mg
T165	frequency 12456 12469	every 4 weeks
T166	indication 12525 12547	Ankylosing Spondylitis
T167	tradename 12572 12578	CIMZIA
T168	indication 12603 12625	ankylosing spondylitis
T169	dose 12629 12635	400 mg
T170	routeofadministration 12649 12661	subcutaneous
T171	dose 12676 12682	200 mg
T172	dose 12733 12739	200 mg
T173	frequency 12740 12753	every 2 weeks
T174	dose 12757 12763	400 mg
T175	frequency 12764 12778	every 4 weeks.
T176	tradename 12819 12825	CIMZIA
T177	tradename 12869 12875	CIMZIA
T178	tradename 12963 12969	CIMZIA
T179	tradename 13218 13224	CIMZIA
T180	tradename 13357 13364	CIMZIA.
T181	tradename 13397 13403	CIMZIA
T182	tradename 13700 13706	CIMZIA
T183	tradename 14095 14101	CIMZIA
T184	tradename 14268 14274	CIMZIA
T185	tradename 14337 14343	CIMZIA
T186	tradename 14571 14577	CIMZIA
T187	dose 14579 14585	200 mg
T188	nanoparticle 14589 14608	certolizumab pegol)
T189	routeofadministration 14748 14762	subcutaneously
T190	dose 14796 14802	400 mg
T191	tradename 14958 14964	CIMZIA
T192	routeofadministration 15018 15030	subcutaneous
T193	tradename 15088 15094	CIMZIA
T194	tradename 15182 15188	CIMZIA
T195	tradename 15420 15427	CIMZIA,
T196	tradename 15896 15902	CIMZIA
T197	tradename 16028 16034	CIMZIA
T198	routeofadministration 16303 16315	subcutaneous
T199	dose 16377 16383	200 mg
T200	tradename 16387 16394	CIMZIA.
T201	dose 16533 16539	200 mg
T202	tradename 16552 16559	CIMZIA.
T203	adversereaction 16784 16802	Serious Infections
T204	tradename 16845 16851	CIMZIA
T205	adversereaction 16892 16910	serious infections
T206	adversereaction 17134 17255	aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis
T207	adversereaction 17260 17272	tuberculosis
T208	tradename 17412 17418	CIMZIA
T209	co-administereddrug 17669 17684	corticosteroids
T210	co-administereddrug 17688 17701	methotrexate)
T211	adversereaction 18218 18230	Tuberculosis
T212	adversereaction 18241 18269	reactivation of tuberculosis
T213	tradename 18342 18349	CIMZIA,
T214	tradename 18555 18561	CIMZIA
T215	tradename 18946 18953	CIMZIA,
T216	tradename 19106 19112	CIMZIA
T217	tradename 19651 19657	CIMZIA
T218	tradename 20175 20182	CIMZIA,
T219	tradename 20411 20426	CIMZIA. CIMZIA
T220	tradename 20565 20571	CIMZIA
T221	adversereaction 20755 20781	Invasive Fungal Infections
T222	adversereaction 21477 21497	Ma l i g n a n ci es
T223	adversereaction 21581 21593	malignancies
T224	tradename 21730 21736	CIMZIA
T225	indication 21748 21763	Crohn's disease
T226	adversereaction 21784 21796	malignancies
T227	tradename 21936 21950	CIMZIA-treated
T228	adversereaction 22194 22207	Malignancies,
T229	tradename 22392 22398	CIMZIA
T230	adversereaction 22447 22457	lymphomas,
T231	adversereaction 22468 22505	Hodgkin's and non-Hodgkin's lymphoma.
T232	adversereaction 22558 22570	malignancies
T233	adversereaction 22589 22601	malignancies
T234	adversereaction 22648 22660	malignancies
T235	adversereaction 22725 22737	malignancies
T236	tradename 23023 23029	CIMZIA
T237	adversereaction 23164 23172	lymphoma
T238	tradename 23286 23292	CIMZIA
T239	indication 23297 23312	Crohn's disease
T240	tradename 23388 23402	Cimzia-treated
T241	tradename 23493 23499	CIMZIA
T242	adversereaction 23581 23589	lymphoma
T243	tradename 23853 23859	CIMZIA
T244	tradename 23977 23983	CIMZIA
T245	indication 24232 24247	Crohn's disease
T246	adversereaction 24382 24391	lymphoma,
T247	adversereaction 24530 24542	malignancies
T248	adversereaction 24591 24629	hepatosplenic T-cell lymphoma (HSTCL),
T249	tradename 24793 24800	CIMZIA.
T250	indication 24894 24909	Crohn's disease
T251	adversereaction 25394 25420	acute and chronic leukemia
T252	adversereaction 25680 25689	leukemia.
T253	adversereaction 25811 25824	Heart Failure
T254	adversereaction 25844 25868	congestive heart failure
T255	tradename 25942 25957	CIMZIA. CIMZIA
T256	adversereaction 26289 26315	Hypersensitivity Reactions
T257	adversereaction 26369 26395	hypersensitivity reactions
T258	tradename 26433 26439	CIMZIA
T259	adversereaction 26469 26524	angioedema, dyspnea, hypotension, rash, serum sickness,
T260	adversereaction 26529 26539	urticaria.
T261	tradename 26607 26614	CIMZIA.
T262	tradename 26678 26684	CIMZIA
T263	tradename 26761 26767	CIMZIA
T264	adversereaction 26810 26835	hypersensitivity reaction
T265	adversereaction 26937 26967	Hepatitis B Virus Reactivation
T266	tradename 26999 27006	CIMZIA,
T267	adversereaction 27032 27072	reactivation of hepatitis B virus (HBV)
T268	tradename 27466 27473	CIMZIA.
T269	tradename 27876 27882	CIMZIA
T270	adversereaction 28070 28087	HBV reactivation,
T271	tradename 28100 28106	CIMZIA
T272	tradename 28516 28522	CIMZIA
T273	tradename 28635 28641	CIMZIA
T274	tradename 28973 28979	CIMZIA
T275	tradename 29240 29246	CIMZIA
T276	adversereaction 29323 29336	pancytopenia,
T277	adversereaction 29347 29363	aplastic anemia,
T278	adversereaction 29480 29489	cytopenia
T279	adversereaction 29497 29540	leukopenia, pancytopenia, thrombocytopenia)
T280	tradename 29578 29584	CIMZIA
T281	tradename 29659 29665	CIMZIA
T282	tradename 29781 29787	CIMZIA
T283	tradename 30060 30067	CIMZIA.
T284	tradename 30097 30103	CIMZIA
T285	tradename 30714 30720	CIMZIA
T286	tradename 30765 30771	CIMZIA
T287	tradename 30899 30905	CIMZIA
T288	adversereaction 30989 31009	lupus-like syndrome.
T289	adversereaction 31058 31077	lupus-like syndrome
T290	tradename 31103 31110	CIMZIA,
T291	tradename 31206 31212	CIMZIA
T292	tradename 31426 31433	CIMZIA.
T293	indication 31491 31512	rheumatoid arthritis,
T294	tradename 31580 31586	CIMZIA
T295	tradename 31719 31726	CIMZIA.
T296	tradename 31822 31828	CIMZIA
T297	tradename 31886 31892	CIMZIA
T298	tradename 31984 31990	CIMZIA
T299	tradename 32193 32200	CIMZIA,
T300	tradename 32446 32452	CIMZIA
T301	adversereaction 32486 32499	malignancies,
T302	tradename 32672 32678	CIMZIA
T303	adversereaction 32850 32868	Serious Infections
T304	adversereaction 32915 32927	Malignancies
T305	adversereaction 32974 32987	Heart Failure
T306	adversereaction 33470 33498	upper respiratory infections
T307	adversereaction 33506 33510	rash
T308	adversereaction 33520 33544	urinary tract infections
T309	indication 33691 33706	Crohn's disease
T310	tradename 33805 33811	CIMZIA
T311	tradename 33901 33907	CIMZIA
T312	adversereaction 33980 33994	abdominal pain
T313	tradename 34001 34008	CIMZIA,
T314	adversereaction 34024 34032	diarrhea
T315	tradename 34039 34046	CIMZIA,
T316	adversereaction 34064 34086	intestinal obstruction
T317	tradename 34093 34100	CIMZIA,
T318	indication 34147 34167	rheumatoid arthritis
T319	tradename 34266 34272	CIMZIA
T320	tradename 34360 34366	CIMZIA
T321	adversereaction 34372 34395	tuberculosis infections
T322	adversereaction 34408 34438	pyrexia, urticaria, pneumonia,
T323	adversereaction 34443 34447	rash
T324	indication 34481 34496	Crohn's Disease
T325	tradename 34542 34548	CIMZIA
T326	dose 34552 34558	400 mg
T327	routeofadministration 34559 34571	subcutaneous
T328	indication 34608 34624	Crohn's disease.
T329	indication 34703 34718	Crohn's disease
T330	tradename 34728 34734	CIMZIA
T331	dose 34748 34755	400 mg,
T332	tradename 34876 34882	CIMZIA
T333	tradename 34967 34973	CIMZIA
T334	dose 35026 35032	400 mg
T335	tradename 35033 35040	CIMZIA.
T336	tradename 35312 35318	CIMZIA
T337	tradename 35403 35417	CIMZIA-treated
T338	tradename 35513 35519	CIMZIA
T339	adversereaction 35525 35553	upper respiratory infections
T340	adversereaction 35560 35605	nasopharyngitis, laryngitis, viral infection)
T341	tradename 35616 35630	CIMZIA-treated
T342	adversereaction 35677 35701	urinary tract infections
T343	adversereaction 35708 35749	bladder infection, bacteriuria, cystitis)
T344	tradename 35759 35773	CIMZIA-treated
T345	adversereaction 35826 35836	arthralgia
T346	tradename 35841 35848	CIMZIA,
T347	indication 36107 36122	Crohn's disease
T348	indication 36245 36260	Crohn's disease
T349	tradename 36313 36319	CIMZIA
T350	dose 36332 36338	400 mg
T351	adversereaction 36402 36452	Anemia, leukopenia, lymphadenopathy, pancytopenia,
T352	adversereaction 36457 36471	thrombophilia.
T353	adversereaction 36492 36674	Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke
T354	adversereaction 36679 36705	transient ischemic attack.
T355	adversereaction 36722 36757	Optic neuritis, retinal hemorrhage,
T356	adversereaction 36762 36770	uveitis.
T357	adversereaction 36826 36834	Bleeding
T358	adversereaction 36839 36864	injection site reactions.
T359	adversereaction 36891 36913	Elevated liver enzymes
T360	adversereaction 36918 36928	hepatitis.
T361	adversereaction 36955 36972	Alopecia totalis.
T362	adversereaction 36997 37023	Anxiety, bipolar disorder,
T363	adversereaction 37028 37044	suicide attempt.
T364	adversereaction 37075 37093	Nephrotic syndrome
T365	adversereaction 37098 37112	renal failure.
T366	adversereaction 37156 37175	Menstrual disorder.
T367	adversereaction 37217 37246	Dermatitis, erythema nodosum,
T368	adversereaction 37251 37261	urticaria.
T369	adversereaction 37283 37312	Thrombophlebitis, vasculitis.
T370	indication 37338 37358	Rheumatoid Arthritis
T371	tradename 37359 37365	CIMZIA
T372	tradename 37504 37510	CIMZIA
T373	indication 37877 37898	rheumatoid arthritis,
T374	tradename 37992 37998	CIMZIA
T375	tradename 38103 38109	CIMZIA
T376	dose 38110 38116	200 mg
T377	frequency 38117 38133	every other week
T378	co-administereddrug 38201 38214	methotrexate.
T379	tradename 38291 38297	CIMZIA
T380	frequency 38304 38320	Every Other Week
T381	indication 38357 38377	Rheumatoid Arthritis
T382	co-administereddrug 38404 38417	Methotrexate.
T383	tradename 38630 38636	CIMZIA
T384	dose 38637 38643	200 mg
T385	adversereaction 38689 38735	Upper respiratory tract 2 6 infection Headache
T386	adversereaction 38740 38752	Hypertension
T387	adversereaction 38757 38772	Nasopharyngitis
T388	adversereaction 38777 38786	Back pain
T389	adversereaction 38791 38798	Pyrexia
T390	adversereaction 38803 38814	Pharyngitis
T391	adversereaction 38819 38823	Rash
T392	adversereaction 38828 38844	Acute bronchitis
T393	adversereaction 38849 38856	Fatigue
T394	frequency 38869 38886	Every other Week,
T395	co-administereddrug 38893 38906	Methotrexate.
T396	tradename 38991 38997	CIMZIA
T397	co-administereddrug 39161 39176	corticosteroids
T398	co-administereddrug 39181 39219	non-steroidal anti-inflammatory drugs.
T399	tradename 39240 39246	CIMZIA
T400	dose 39247 39253	400 mg
T401	frequency 39269 39282	every 4 weeks
T402	indication 39286 39306	rheumatoid arthritis
T403	tradename 39392 39398	CIMZIA
T404	dose 39399 39405	200 mg
T405	frequency 39406 39423	every other week.
T406	indication 39558 39573	Crohn's disease
T407	indication 39585 39604	Psoriatic Arthritis
T408	tradename 39620 39626	CIMZIA
T409	indication 39665 39690	psoriatic arthritis (PsA)
T410	tradename 39776 39782	CIMZIA
T411	tradename 39871 39878	CIMZIA.
T412	indication 39880 39902	Ankylosing Spondylitis
T413	tradename 39918 39924	CIMZIA
T414	indication 40012 40039	ankylosing spondylitis (AS)
T415	tradename 40137 40143	CIMZIA
T416	indication 40269 40284	Crohn's disease
T417	tradename 40297 40311	CIMZIA-treated
T418	adversereaction 40399 40427	upper respiratory infections
T419	tradename 40437 40444	CIMZIA,
T420	adversereaction 40481 40499	serious infections
T421	tradename 40567 40581	CIMZIA-treated
T422	adversereaction 40628 40646	Serious infections
T423	adversereaction 40665 40707	bacterial and viral infections, pneumonia,
T424	adversereaction 40712 40727	pyelonephritis.
T425	indication 40804 40824	rheumatoid arthritis
T426	tradename 40859 40873	CIMZIA-treated
T427	adversereaction 40978 41058	upper respiratory tract infections, herpes infections, urinary tract infections,
T428	adversereaction 41063 41098	lower respiratory tract infections.
T429	indication 41118 41138	rheumatoid arthritis
T430	tradename 41220 41226	CIMZIA
T431	tradename 41307 41313	CIMZIA
T432	dose 41396 41402	200 mg
T433	frequency 41403 41419	every other week
T434	dose 41655 41661	400 mg
T435	frequency 41662 41675	every 4 weeks
T436	adversereaction 41743 41779	tuberculosis, pneumonia, cellulitis,
T437	adversereaction 41784 41799	pyelonephritis.
T438	tradename 42132 42146	CIMZIA-treated
T439	adversereaction 42178 42190	tuberculosis
T440	tradename 42478 42484	CIMZIA
T441	tradename 42543 42549	CIMZIA
T442	adversereaction 42770 42782	Malignancies
T443	tradename 42806 42813	CIMZIA,
T444	adversereaction 42844 42856	malignancies
T445	tradename 42874 42888	CIMZIA-treated
T446	adversereaction 42949 42961	malignancies
T447	adversereaction 43093 43106	Heart Failure
T448	indication 43144 43164	rheumatoid arthritis
T449	adversereaction 43201 43214	heart failure
T450	tradename 43238 43252	CIMZIA-treated
T451	indication 43439 43455	Crohn's disease,
T452	tradename 43484 43490	CIMZIA
T453	indication 43634 43649	Crohn's disease
T454	tradename 43672 43678	CIMZIA
T455	adversereaction 43703 43723	lupus-like syndrome.
T456	tradename 43771 43778	CIMZIA,
T457	tradename 43884 43890	CIMZIA
T458	tradename 44016 44022	CIMZIA
T459	nanoparticle 44193 44211	certolizumab pegol
T460	tradename 44338 44345	CIMZIA,
T461	indication 44709 44724	Crohn's disease
T462	adversereaction 44858 44986	abdominal pain, arthralgia, edema peripheral, erythema nodosum, injection site erythema, injection site pain, pain in extremity,
T463	adversereaction 44991 45025	upper respiratory tract infection.
T464	nanoparticle 45081 45099	certolizumab pegol
T465	indication 45165 45185	rheumatoid arthritis
T466	tradename 45810 45816	CIMZIA
T467	dose 45877 45883	400 mg
T468	frequency 45884 45900	every other week
T469	tradename 46128 46134	CIMZIA
T470	dose 46145 46151	200 mg
T471	frequency 46152 46168	every other week
T472	nanoparticle 46860 46878	certolizumab pegol
T473	nanoparticle 47323 47341	certolizumab pegol
T474	adversereaction 47413 47439	Hypersensitivity Reactions
T475	adversereaction 47493 47519	hypersensitivity reactions
T476	tradename 47557 47563	CIMZIA
T477	adversereaction 47592 47723	angioedema, dermatitis allergic, dizziness (postural), dyspnea, hot flush, hypotension, injection site reactions, malaise, pyrexia,
T478	adversereaction 47730 47745	serum sickness,
T479	adversereaction 47750 47769	(vasovagal) syncope
T480	tradename 47920 47927	CIMZIA.
T481	adversereaction 48150 48169	systemic vasculitis
T482	adversereaction 48280 48354	Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme,
T483	adversereaction 48376 48385	psoriasis
T484	adversereaction 48527 48538	sarcoidosis
T485	tradename 49036 49042	CIMZIA
T486	tradename 49349 49355	CIMZIA
T487	tradename 49567 49573	CIMZIA
T488	tradename 49724 49731	CIMZIA.
T489	nanoparticle 49733 49751	Certolizumab pegol
T490	tradename 50337 50343	CIMZIA
T491	tradename 50513 50519	CIMZIA
T492	nanoparticle 50563 50581	Certolizumab pegol
T493	tradename 50640 50646	CIMZIA
T494	nanoparticle 50730 50749	certolizumab pegol.
T495	tradename 50751 50757	CIMZIA
T496	tradename 51137 51143	CIMZIA
T497	indication 51313 51328	Crohn's disease
T498	tradename 51343 51350	CIMZIA,
T499	nanoparticle 51351 51369	certolizumab pegol
T500	tradename 51498 51504	CIMZIA
T501	dose 51506 51512	400 mg
T502	nanoparticle 51604 51622	certolizumab pegol
T503	nanoparticle 51762 51780	certolizumab pegol
T504	nanoparticle 51893 51912	certolizumab pegol.
T505	nanoparticle 51939 51957	certolizumab pegol
T506	tradename 52034 52040	CIMZIA
T507	nanoparticle 52121 52139	certolizumab pegol
T508	surfacecoating 52274 52283	pegylated
T509	activeingredient 52284 52297	Fab' fragment
T510	nanoparticle 52319 52338	certolizumab pegol.
T511	dose 52404 52413	100 mg/kg
T512	nanoparticle 52548 52566	certolizumab pegol
T513	tradename 52886 52893	CIMZIA,
T514	tradename 53168 53174	CIMZIA
T515	nanoparticle 53288 53306	certolizumab pegol
T516	tradename 53348 53354	CIMZIA
T517	tradename 53487 53493	CIMZIA
T518	tradename 53831 53837	CIMZIA
T519	tradename 54155 54161	CIMZIA
T520	tradename 54400 54406	CIMZIA
T521	nanoparticle 54490 54508	certolizumab pegol
T522	dose 54551 54558	800 mg
T523	routeofadministration 54559 54571	subcutaneous
T524	dose 54576 54584	20 mg/kg
T525	routeofadministration 54585 54596	intravenous
T526	tradename 54860 54866	CIMZIA
T527	nanoparticle 54868 54887	certolizumab pegol)
T528	tradename 54907 54913	CIMZIA
T529	activeingredient 54919 54966	recombinant, humanized antibody Fab' fragment,
T530	molecularweight 55067 55072	40kDa
T531	surfacecoating 55073 55092	polyethylene glycol
T532	surfacecoating 55094 55105	PEG2MAL40K)
T533	activeingredient 55112 55125	Fab' fragment
T534	surfacecoating 55218 55229	PEG2MAL40K,
T535	nanoparticle 55242 55261	certolizumab pegol.
T536	activeingredient 55267 55280	Fab' fragment
T537	nanoparticle 55396 55414	certolizumab pegol
T538	molecularweight 55432 55447	91 kiloDaltons.
T539	tradename 55449 55455	CIMZIA
T540	routeofadministration 55603 55615	subcutaneous
T541	nanoparticle 55810 55829	certolizumab pegol,
T542	inactiveingredient 55837 55849	lactic acid,
T543	inactiveingredient 55857 55869	polysorbate,
T544	inactiveingredient 55881 55889	sucrose.
T545	tradename 55928 55934	CIMZIA
T546	routeofadministration 56006 56018	subcutaneous
T547	tradename 56046 56052	CIMZIA
T548	nanoparticle 56062 56080	certolizumab pegol
T549	inactiveingredient 56091 56105	sodium acetate
T550	inactiveingredient 56117 56132	sodium chloride
T551	inactiveingredient 56148 56153	Water
T552	tradename 56175 56181	CIMZIA
T553	nanoparticle 56550 56568	Certolizumab pegol
T554	nanoparticle 56710 56728	Certolizumab pegol
T555	nanoparticle 56929 56947	Certolizumab pegol
T556	nanoparticle 57132 57150	Certolizumab pegol
T557	nanoparticle 57282 57300	certolizumab pegol
T558	nanoparticle 57408 57426	Certolizumab pegol
T559	nanoparticle 57743 57761	certolizumab pegol
T560	nanoparticle 57888 57906	certolizumab pegol
T561	nanoparticle 57951 57969	Certolizumab pegol
T562	indication 58545 58560	Crohn's disease
T563	indication 58565 58586	rheumatoid arthritis.
T564	nanoparticle 58588 58606	Certolizumab pegol
T565	indication 58756 58771	Crohn's disease
T566	indication 58828 58843	Crohn's disease
T567	nanoparticle 58926 58945	certolizumab pegol,
T568	indication 58960 58975	Crohn's disease
T569	indication 59107 59127	rheumatoid arthritis
T570	dose 59325 59331	800 mg
T571	nanoparticle 59332 59350	certolizumab pegol
T572	routeofadministration 59351 59370	subcutaneously (sc)
T573	dose 59381 59389	10 mg/kg
T574	routeofadministration 59390 59408	intravenously (IV)
T575	routeofadministration 59490 59501	intravenous
T576	routeofadministration 59506 59518	subcutaneous
T577	nanoparticle 59528 59546	certolizumab pegol
T578	nanoparticle 59724 59742	certolizumab pegol
T579	cmax 59818 59833	43 to 49 mcg/mL
T580	indication 59962 59982	rheumatoid arthritis
T581	dose 59984 59990	400 mg
T582	dose 60026 60032	200 mg
T583	frequency 60033 60050	every other week)
T584	nanoparticle 60053 60071	Certolizumab pegol
T585	indication 60172 60192	rheumatoid arthritis
T586	indication 60197 60212	Crohn's disease
T587	routeofadministration 60277 60289	subcutaneous
T588	nanoparticle 60336 60354	certolizumab pegol
T589	tmax 60377 60393	54 and 171 hours
T590	nanoparticle 60411 60429	Certolizumab pegol
T591	routeofadministration 60670 60682	subcutaneous
T592	routeofadministration 60710 60721	intravenous
T593	volumeofdistribution 60824 60832	6 to 8 L
T594	indication 60895 60910	Crohn's disease
T595	indication 60929 60950	rheumatoid arthritis.
T596	nanoparticle 60990 61008	certolizumab pegol
T597	activeingredient 61104 61117	Fab' fragment
T598	surfacecoating 61122 61125	PEG
T599	surfacecoating 61250 61262	PEG polymers
T600	nanoparticle 61466 61484	certolizumab pegol
T601	activeingredient 61491 61513	antibody Fab' fragment
T602	surfacecoating 61530 61533	PEG
T603	activeingredient 61609 61614	Fab'.
T604	eliminationhalflife 61681 61688	14 days
T605	routeofadministration 61735 61737	IV
T606	clearance 61785 61809	9.21 mL/h to 14.38 mL/h.
T607	routeofadministration 61834 61836	sc
T608	clearance 61858 61865	17 mL/h
T609	indication 61873 61888	Crohn's disease
T610	routeofadministration 62037 62039	sc
T611	clearance 62064 62073	21.0 mL/h
T612	nanoparticle 62224 62242	certolizumab pegol
T613	surfacecoating 62354 62357	PEG
T614	indication 62501 62521	rheumatoid arthritis
T615	indication 62541 62557	Crohn's disease,
T616	nanoparticle 62734 62753	certolizumab pegol.
T617	nanoparticle 62839 62857	certolizumab pegol
T618	nanoparticle 63211 63229	certolizumab pegol
T619	nanoparticle 63314 63332	certolizumab pegol
T620	tradename 63511 63518	CIMZIA.
T621	surfacecoating 63547 63550	PEG
T622	surfacecoating 63552 63572	polyethylene glycol)
T623	nanoparticle 63585 63603	certolizumab pegol
T624	co-administereddrug 64094 64106	Methotrexate
T625	tradename 64174 64180	CIMZIA
T626	indication 64199 64220	rheumatoid arthritis.
T627	co-administereddrug 64235 64247	methotrexate
T628	tradename 64251 64257	CIMZIA
T629	co-administereddrug 64301 64321	methotrexate-treated
T630	tradename 64369 64376	CIMZIA.
T631	tradename 64446 64452	CIMZIA
T632	co-administereddrug 64474 64486	methotrexate
T633	indication 64504 64525	rheumatoid arthritis.
T634	tradename 64592 64598	CIMZIA
T635	co-administereddrug 64636 64690	corticosteroids, nonsteroidal anti-inflammatory drugs,
T636	tradename 64843 64849	CIMZIA
T637	nanoparticle 64914 64932	Certolizumab pegol
T638	nanoparticle 65090 65108	certolizumab pegol
T639	surfacecoating 65242 65251	pegylated
T640	activeingredient 65252 65264	Fab fragment
T641	nanoparticle 65287 65306	certolizumab pegol.
T642	routeofadministration 65416 65427	intravenous
T643	dose 65437 65447	100 mg/kg,
T644	frequency 65461 65474	twice weekly.
T645	indication 65502 65517	Crohn's Disease
T646	tradename 65545 65551	CIMZIA
T647	indication 65698 65714	Crohn's disease,
T648	indication 65731 65746	Crohn's Disease
T649	tradename 65804 65810	CIMZIA
T650	routeofadministration 65828 65842	subcutaneously
T651	dose 65856 65862	400 mg
T652	indication 65916 65931	Crohn's disease
T653	indication 66039 66056	Crohn's disease.
T654	tradename 66058 66064	CIMZIA
T655	frequency 66123 66139	every four weeks
T656	tradename 66526 66540	CIMZIA-treated
T657	tradename 67178 67184	CIMZIA
T658	dose 67185 67191	400 mg
T659	indication 67811 67827	Crohn's disease.
T660	tradename 67890 67896	CIMZIA
T661	tradename 68117 68123	CIMZIA
T662	tradename 68748 68762	CIMZIA-treated
T663	tradename 68909 68915	CIMZIA
T664	dose 68916 68922	400 mg
T665	tradename 68946 68952	CIMZIA
T666	dose 68953 68959	400 mg
T667	tradename 69327 69334	CIMZIA.
T668	indication 69622 69642	Rheumatoid Arthritis
T669	tradename 69670 69676	CIMZIA
T670	indication 69859 69879	rheumatoid arthritis
T671	tradename 70066 70072	CIMZIA
T672	routeofadministration 70090 70104	subcutaneously
T673	dose 70157 70162	10 mg
T674	frequency 70163 70169	weekly
T675	tradename 70207 70213	CIMZIA
T676	dose 70470 70476	400 mg
T677	dose 70553 70559	200 mg
T678	dose 70563 70569	400 mg
T679	tradename 70573 70579	CIMZIA
T680	frequency 70591 70608	every other week,
T681	duration 70637 70645	52 weeks
T682	duration 70668 70676	24 weeks
T683	dose 70950 70956	400 mg
T684	tradename 70960 70966	CIMZIA
T685	frequency 70967 70984	every other week.
T686	dose 71134 71140	400 mg
T687	tradename 71144 71150	CIMZIA
T688	frequency 71151 71167	every four weeks
T689	duration 71172 71180	24 weeks
T690	tradename 71399 71406	CIMZIA.
T691	tradename 71435 71441	CIMZIA
T692	dose 71442 71448	400 mg
T693	frequency 71460 71473	every 4 weeks
T694	duration 71478 71487	24 weeks.
T695	tradename 71611 71625	CIMZIA-treated
T696	tradename 71722 71736	CIMZIA-treated
T697	tradename 72052 72066	CIMZIA-treated
T698	co-administereddrug 72324 72336	Methotrexate
T699	duration 72351 72367	24 and 52 weeks)
T700	duration 72395 72404	24 weeks)
T701	tradename 72428 72435	CIMZIA(
T702	dose 72438 72444	200 mg
T703	tradename 72469 72476	CIMZIA(
T704	dose 72479 72485	200 mg
T705	tradename 72536 72543	CIMZIA(
T706	dose 72546 72552	400 mg
T707	tradename 72571 72578	CIMZIA(
T708	dose 72581 72587	400 mg
T709	tradename 73015 73021	CIMZIA
T710	frequency 73035 73049	every 2 weeks
T711	dose 73081 73087	400 mg
T712	tradename 73113 73119	CIMZIA
T713	frequency 73133 73147	every 4 weeks
T714	tradename 73720 73727	CIMZIA(
T715	dose 73730 73736	200 mg
T716	tradename 73782 73789	CIMZIA(
T717	dose 73792 73798	400 mg
T718	tradename 74431 74437	CIMZIA
T719	frequency 74451 74464	every 2 weeks
T720	dose 74495 74501	400 mg
T721	tradename 74526 74532	CIMZIA
T722	frequency 74546 74559	every 4 weeks
T723	tradename 75341 75347	CIMZIA
T724	dose 75348 75354	200 mg
T725	tradename 75542 75549	CIMZIA,
T726	tradename 76061 76067	CIMZIA
T727	tradename 76325 76331	CIMZIA
T728	dose 76332 76338	200 mg
T729	frequency 76339 76355	every other week
T730	tradename 76696 76702	CIMZIA
T731	dose 76703 76709	200 mg
T732	tradename 76712 76718	CIMZIA
T733	dose 76719 76725	200 mg
T734	tradename 77327 77341	CIMZIA-treated
T735	indication 77591 77610	Psoriatic Arthritis
T736	tradename 77639 77645	CIMZIA
T737	indication 77791 77810	psoriatic arthritis
T738	indication 77995 78014	Psoriatic Arthritis
T739	tradename 78368 78374	CIMZIA
T740	dose 78375 78381	400 mg
T741	tradename 78459 78465	CIMZIA
T742	dose 78466 78472	200 mg
T743	frequency 78473 78489	every other week
T744	tradename 78493 78499	CIMZIA
T745	dose 78500 78506	400 mg
T746	frequency 78507 78521	every 4 weeks
T747	frequency 78533 78550	every other week.
T748	tradename 78745 78759	CIMZIA-treated
T749	tradename 78906 78912	CIMZIA
T750	dose 79218 79224	200 mg
T751	tradename 79334 79340	CIMZIA
T752	dose 79341 79347	400 mg
T753	tradename 79614 79628	CIMZIA-treated
T754	dose 79655 79661	200 mg
T755	frequency 79662 79675	every 2 weeks
T756	dose 79679 79685	400 mg
T757	frequency 79686 79699	every 4 weeks
T758	tradename 79913 79919	CIMZIA
T759	tradename 80026 80032	CIMZIA
T760	tradename 80193 80200	CIMZIA(
T761	dose 80202 80208	200 mg
T762	tradename 80209 80216	CIMZIA(
T763	dose 80219 80225	400 mg
T764	tradename 80394 80400	CIMZIA
T765	frequency 80414 80427	every 2 weeks
T766	dose 80458 80464	400 mg
T767	tradename 80489 80495	CIMZIA
T768	frequency 80509 80522	every 4 weeks
T769	dose 80553 80559	400 mg
T770	tradename 80795 80802	CIMZIA(
T771	dose 80805 80811	200 mg
T772	tradename 80823 80830	CIMZIA(
T773	dose 80833 80839	400 mg
T774	tradename 81447 81453	CIMZIA
T775	frequency 81467 81480	every 2 weeks
T776	dose 81511 81517	400 mg
T777	tradename 81542 81548	CIMZIA
T778	frequency 81562 81575	every 4 weeks
T779	dose 81606 81612	400 mg
T780	tradename 83021 83027	CIMZIA
T781	dose 83028 83034	200 mg
T782	frequency 83035 83051	every other week
T783	tradename 83305 83311	CIMZIA
T784	dose 83312 83318	200 mg
T785	tradename 83395 83401	CIMZIA
T786	dose 83402 83408	400 mg
T787	frequency 83409 83425	every four weeks
T788	tradename 83589 83603	CIMZIA-treated
T789	tradename 83859 83865	CIMZIA
T790	dose 83866 83872	200 mg
T791	tradename 83941 83947	CIMZIA
T792	dose 83948 83954	400 mg
T793	indication 84015 84037	Ankylosing Spondylitis
T794	tradename 84066 84072	CIMZIA
T795	indication 84229 84252	axial spondyloarthritis
T796	indication 84381 84403	Ankylosing Spondylitis
T797	tradename 84654 84660	CIMZIA
T798	dose 84661 84667	400 mg
T799	dose 84744 84750	200 mg
T800	tradename 84754 84760	CIMZIA
T801	frequency 84761 84774	every 2 weeks
T802	dose 84778 84784	400 mg
T803	tradename 84788 84794	CIMZIA
T804	frequency 84795 84808	every 4 weeks
T805	co-administereddrug 84833 84839	NSAIDs
T806	tradename 85079 85085	CIMZIA
T807	dose 85086 85091	200mg
T808	frequency 85092 85105	every 2 weeks
T809	dose 85109 85114	400mg
T810	frequency 85115 85128	every 4 weeks
T811	tradename 85258 85264	CIMZIA
T812	dose 85265 85271	200 mg
T813	frequency 85272 85285	every 2 weeks
T814	tradename 85290 85296	CIMZIA
T815	dose 85297 85303	400 mg
T816	frequency 85304 85318	every 4 weeks.
T817	tradename 85734 85741	CIMZIA(
T818	dose 85744 85749	200mg
T819	frequency 85750 85763	every 2 weeks
T820	tradename 85770 85777	CIMZIA(
T821	dose 85780 85785	400mg
T822	frequency 85786 85799	every 4 weeks
T823	tradename 85903 85909	CIMZIA
T824	frequency 85923 85936	every 2 weeks
T825	dose 85967 85973	400 mg
T826	tradename 85998 86004	CIMZIA
T827	frequency 86018 86031	every 4 weeks
T828	dose 86062 86068	400 mg
T829	tradename 86336 86343	CIMZIA(
T830	dose 86346 86351	200mg
T831	frequency 86352 86365	every 2 weeks
T832	tradename 86373 86380	CIMZIA(
T833	dose 86383 86388	400mg
T834	frequency 86389 86402	every 4 weeks
T835	tradename 86761 86767	CIMZIA
T836	frequency 86781 86794	every 2 weeks
T837	dose 86825 86831	400 mg
T838	tradename 86854 86860	CIMZIA
T839	frequency 86874 86887	every 4 weeks
T840	dose 86918 86924	400 mg
T841	indication 86962 86984	Ankylosing Spondylitis
T842	indication 87019 87041	Ankylosing Spondylitis
T843	indication 87082 87104	Ankylosing Spondylitis
T844	tradename 87314 87321	CIMZIA,
T845	indication 87692 87707	Crohn's Disease
T846	indication 87745 87760	Crohn's Disease
T847	tradename 88288 88294	CIMZIA
T848	tradename 88858 88865	CIMZIA.
T849	tradename 89223 89230	CIMZIA.
T850	tradename 89399 89405	CIMZIA
T851	tradename 89517 89523	CIMZIA
T852	tradename 89712 89718	CIMZIA
T853	tradename 89935 89941	CIMZIA
T854	tradename 90280 90287	CIMZIA.
T855	adversereaction 90298 90316	Allergic Reactions
T856	adversereaction 90759 90768	cytopenia
T857	routeofadministration 90946 90958	subcutaneous
T858	tradename 91011 91017	CIMZIA
T859	tradename 91140 91146	CIMZIA
T860	routeofadministration 91147 91159	subcutaneous
T861	tradename 91284 91290	CIMZIA
T862	tradename 91472 91478	CIMZIA
T863	company 92011 92020	UCB, Inc.
T864	tradename 92234 92240	CIMZIA
T865	nanoparticle 92257 92276	certolizumab pegol)
T866	routeofadministration 92314 92326	subcutaneous
T867	tradename 92375 92381	CIMZIA
T868	tradename 92438 92445	CIMZIA.
T869	tradename 92636 92651	CIMZIA? CIMZIA
T870	tradename 92699 92705	CIMZIA
T871	tradename 92823 92830	CIMZIA.
T872	adversereaction 92857 92874	tuberculosis (TB)
T873	tradename 93081 93088	CIMZIA.
T874	tradename 93196 93203	CIMZIA.
T875	tradename 93236 93242	CIMZIA
T876	tradename 93346 93353	CIMZIA,
T877	tradename 94686 94693	CIMZIA.
T878	tradename 95013 95020	CIMZIA,
T879	tradename 95200 95206	CIMZIA
T880	tradename 95496 95503	CIMZIA,
T881	adversereaction 95527 95535	lymphoma
T882	adversereaction 95683 95692	lymphoma.
T883	tradename 95702 95717	CIMZIA? CIMZIA
T884	tradename 95791 95797	CIMZIA
T885	indication 95902 95922	Crohn's disease (CD)
T886	indication 96034 96059	rheumatoid arthritis (RA)
T887	indication 96084 96103	psoriatic arthritis
T888	indication 96128 96150	ankylosing spondylitis
T889	tradename 96359 96374	CIMZIA? CIMZIA
T890	tradename 96418 96425	CIMZIA,
T891	tradename 96608 96615	CIMZIA?
T892	tradename 96925 96932	CIMZIA.
T893	tradename 96986 96993	CIMZIA.
T894	tradename 97064 97071	CIMZIA.
T895	tradename 97147 97153	CIMZIA
T896	tradename 97262 97269	CIMZIA.
T897	tradename 97327 97334	CIMZIA,
T898	tradename 97425 97432	CIMZIA.
T899	tradename 97567 97573	CIMZIA
T900	tradename 97663 97669	CIMZIA
T901	tradename 97767 97773	CIMZIA
T902	tradename 98516 98522	CIMZIA
T903	tradename 98585 98592	CIMZIA?
T904	tradename 98604 98610	CIMZIA
T905	tradename 98748 98754	CIMZIA
T906	tradename 98768 98774	CIMZIA
T907	tradename 98833 98839	CIMZIA
T908	tradename 98991 98997	CIMZIA
T909	tradename 99054 99061	CIMZIA.
T910	tradename 99092 99098	CIMZIA
T911	tradename 99201 99208	CIMZIA.
T912	tradename 99329 99336	CIMZIA,
T913	tradename 99453 99459	CIMZIA
T914	tradename 99663 99669	CIMZIA
T915	tradename 99784 99791	CIMZIA.
T916	tradename 99808 99814	CIMZIA
T917	tradename 99946 99953	CIMZIA.
T918	tradename 99965 99971	CIMZIA
T919	tradename 100317 100323	CIMZIA
T920	tradename 100451 100458	CIMZIA.
T921	tradename 100773 100787	CIMZIA? CIMZIA
T922	tradename 100905 100912	CIMZIA?
T923	adversereaction 100924 100937	Heart Failure
T924	adversereaction 101120 101139	Allergic Reactions.
T925	adversereaction 101152 101169	allergic reaction
T926	adversereaction 101180 101248	skin rash, swelling or itching of the face, tongue, lips, or throat,
T927	adversereaction 101252 101270	trouble breathing.
T928	adversereaction 101282 101312	Hepatitis B virus reactivation
T929	tradename 101520 101526	CIMZIA
T930	adversereaction 102464 102484	lupus-like syndrome.
T931	tradename 102725 102731	CIMZIA
T932	adversereaction 102752 102780	upper respiratory infections
T933	adversereaction 102782 102792	flu, cold)
T934	adversereaction 102804 102808	rash
T935	adversereaction 102820 102844	urinary tract infections
T936	adversereaction 102846 102865	bladder infections)
T937	tradename 103008 103015	CIMZIA.
T938	tradename 103214 103221	CIMZIA?
T939	tradename 103238 103244	CIMZIA
T940	tradename 103321 103328	CIMZIA.
T941	tradename 103348 103354	CIMZIA
T942	tradename 103373 103379	CIMZIA
T943	tradename 103428 103434	CIMZIA
T944	tradename 103540 103546	CIMZIA
T945	tradename 103623 103629	CIMZIA
T946	tradename 103735 103742	CIMZIA.
T947	tradename 103958 103964	CIMZIA
T948	tradename 104027 104033	CIMZIA
T949	tradename 104191 104198	CIMZIA.
T950	tradename 104344 104350	CIMZIA
T951	tradename 104426 104433	CIMZIA.
T952	tradename 104490 104505	CIMZIA? CIMZIA
T953	nanoparticle 104546 104564	certolizumab pegol
T954	inactiveingredient 104588 104621	lactic acid, polysorbate, sucrose
T955	tradename 104623 104629	CIMZIA
T956	inactiveingredient 104671 104676	Water
T957	tradename 104693 104699	CIMZIA
T958	nanoparticle 104739 104757	certolizumab pegol
T959	inactiveingredient 104782 104820	sodium acetate, sodium chloride, Water
T960	tradename 104838 104844	CIMZIA
T961	company 104981 104990	UCB, Inc.
T962	tradename 105221 105227	CIMZIA
T963	nanoparticle 105243 105262	certolizumab pegol)
T964	routeofadministration 105278 105290	subcutaneous
T965	tradename 105372 105378	CIMZIA
T966	tradename 105439 105446	CIMZIA.
T967	tradename 105717 105724	CIMZIA.
T968	tradename 105744 105750	CIMZIA
T969	tradename 105920 105926	CIMZIA
T970	tradename 105978 105984	CIMZIA
T971	tradename 106042 106048	CIMZIA
T972	tradename 106361 106367	CIMZIA
T973	tradename 106433 106439	CIMZIA
T974	tradename 106606 106612	CIMZIA
T975	tradename 106686 106692	CIMZIA
T976	tradename 107647 107653	CIMZIA
T977	tradename 108134 108141	CIMZIA.
T978	tradename 108814 108820	CIMZIA
T979	company 112052 112061	UCB, Inc.
